Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-25-013541

Director acquired 1,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Galante Joseph C Director 2025-03-17 Grant or award +1,000 $5.17 $5,170 61,856 D
Loading xslF345X05/wk-form4_1742332404.xml…